RecoVET

LXCL:Support ARCA with a Suggested Donation Your generosity helps ARCA provide meaningful experiences and essential support. Every contribution, big or small, makes a difference.

General Admission

Join us for an eye-opening evening as the Tribeca Screening Room presents the screening of Antagonist: How a Wonder Drug Got Sidelined, an investigative documentary by acclaimed journalist and filmmaker Ben Westhoff.<p fr-original-style="box-sizing: inherit; max-width: 100%; color: rgb(233, 238, 241); width: 550px; margin-inline: 0px !important; font-family: Roboto, Helvetica, Arial, sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: 0.25px; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(26, 79, 117); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; margin: 0px; line-height: 1.5;" style="box-sizing: inherit; max-width: 100%; color: rgb(233, 238, 241); width: 550px; font-family: Roboto, Helvetica, Arial, sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: 0.25px; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(26, 79, 117); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; line-height: 1.5; margin-inline: 0px !important; margin: 0px;"> This powerful film explores the untold story of how a life-saving medication, naltrexone, faced resistance from big-money interests despite its potential to combat opioid and alcohol addiction. Don&rsquo;t miss this chance to engage in meaningful dialogue and learn how you can make a difference.<p fr-original-style="box-sizing: inherit; max-width: 100%; color: rgb(233, 238, 241); width: 535px; font-family: Roboto, Helvetica, Arial, sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: 0.25px; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(26, 79, 117); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; line-height: 1.5; margin: 0px; margin-inline: 0px !important;" style="box-sizing: inherit; max-width: 100%; color: rgb(233, 238, 241); width: 535px; font-family: Roboto, Helvetica, Arial, sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: 0.25px; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(26, 79, 117); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; line-height: 1.5; margin-inline: 0px !important; margin: 0px;"> Event Details: Wednesday, May 20, 2026, 6:30-9 pm6:30 pm &mdash; Panel Discussion featuring director Ben Westhoff, film subject Percy Menzies, Dr. Adam Bisaga, and Dr. Nikej Shaw7:00 pm &ndash; Film<p fr-original-style="box-sizing: inherit; max-width: 100%; color: rgb(233, 238, 241); width: 535px; font-family: Roboto, Helvetica, Arial, sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: 0.25px; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(26, 79, 117); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; line-height: 1.5; margin: 0px; margin-inline: 0px !important;" style="box-sizing: inherit; max-width: 100%; color: rgb(233, 238, 241); width: 535px; font-family: Roboto, Helvetica, Arial, sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: 0.25px; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(26, 79, 117); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; line-height: 1.5; margin-inline: 0px !important; margin: 0px;"> Admission is free! We invite you to consider donating to Assisted Recovery Centers of America<p fr-original-style="box-sizing: inherit; max-width: 100%; color: rgb(233, 238, 241); width: 535px; font-family: Roboto, Helvetica, Arial, sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: 0.25px; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(26, 79, 117); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; line-height: 1.5; margin: 0px; margin-inline: 0px !important;" style="box-sizing: inherit; max-width: 100%; color: rgb(233, 238, 241); width: 535px; font-family: Roboto, Helvetica, Arial, sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: 0.25px; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(26, 79, 117); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; line-height: 1.5; margin-inline: 0px !important; margin: 0px;"> Tribeca Screening Room375 Greenwich Street, New York, NY 10013<p fr-original-style="box-sizing: inherit; max-width: 100%; color: rgb(233, 238, 241); width: 535px; font-family: Roboto, Helvetica, Arial, sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: 0.25px; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(26, 79, 117); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; line-height: 1.5; margin: 0px; margin-inline: 0px !important;" style="box-sizing: inherit; max-width: 100%; color: rgb(233, 238, 241); width: 535px; font-family: Roboto, Helvetica, Arial, sans-serif; font-size: 14px; font-style: normal; font-variant-ligatures: normal; font-variant-caps: normal; font-weight: 400; letter-spacing: 0.25px; orphans: 2; text-align: start; text-indent: 0px; text-transform: none; widows: 2; word-spacing: 0px; -webkit-text-stroke-width: 0px; white-space: normal; background-color: rgb(26, 79, 117); text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; line-height: 1.5; margin-inline: 0px !important; margin: 0px;"> Visit AntagonistFilm.com for more information. Ben Westhoff is an award-winning investigative reporter and author of the best-selling book Fentanyl, Inc.: How Rogue Chemists Created the Deadliest Wave of the Opioid Epidemic. He has advised officials at the top levels of government about the opioid crisis, and has been interviewed as an expert commentator by CNN, NPR, and The New York Times. His new documentary, Antagonist, concerns the suppression of the opioid treatment drug naltrexone by big-money interests. &nbsp; &nbsp;Percy Menzies is the president of Assisted Recovery Centers of America, LLC, a center for the treatment of alcoholism and drug addiction based in St. Louis, Missouri which was established in 2001.He worked for over 18 years for DuPont Pharmaceuticals; one of his roles was associate product director for naltrexone. He has worked closely with drug courts and provided training on the use of anti-craving medications for addiction to reduce recidivism within the criminal justice system. He has conducted workshops for a wide range of audiences both in the US and overseas on evidenced-based treatments for substance use disorders. He has been invited to serve on expert committees to develop guidelines for the treatment of addictive disorders and alcoholism. Percy is a member of the Missouri Opioid State Targeted Response Team. Percy serves on the Missouri State Advisory Council for the Division of Behavioral Health. Percy holds a master&rsquo;s degree in pharmacy. Dr. Adam Bisaga is a Professor of Psychiatry at Columbia University College of Physicians and Surgeons and a Research Scientist at New York State Psychiatric Institute. His research has been continuously funded by NIH for 25 years and is focused on development and implementation of new medications and protocols to treat opioid and other substance use disorders, with recent focus on developing antagonist-based treatments. Dr. Bisaga authored more than 120 scientific publications and published a book &ldquo;Overcoming Opioid Addiction&ldquo; written for both professional and lay audiences. &nbsp;He is a member of UN Office of Drugs and Crime Expert Panel and a WHO consultant and actively collaborates with United Nations agencies to train healthcare providers and develop international treatment guidelines and programs. Additionally, Dr. Bisaga is at the forefront of integrating technology in addiction healthcare as the Medical Director of Ophelia, a telehealth company specializing in the treatment of opioid use disorder.&nbsp; Dr. Nikej Shah is Founder/ CEO of Nirsum and Co-Inventor of its foundational intellectual property. He is also Co-Principal Investigator on Nirsum&rsquo;s Cooperative Agreement with the National Institutes of Health (NIH)/ National Institute On Drug Abuse (NIDA). He brings over 25 years of experience in various roles as a physician-scientist, entrepreneur, and investor. Dr. Shah is also the Founder and Managing Partner of biotech-focused investment firm Mountain Brook Capital, the Founding Investor in Nirsum. He was previously a Senior Healthcare Portfolio Manager at Sigma Capital Management (now Point 72), and at HBK Capital Management. He was also a Managing Director at healthcare public/private equity investor Great Point Partners and Analyst at Ursus Capital. Dr. Shah earned an M.D. at the New York University School of Medicine and B.S. at Cornell University. He was a practicing emergency physician, having completed residency at the New York University/Bellevue Hospital Center, where he gained extensive experience with the acute treatment and referral of patients with opioid use disorder (OUD).

Join us for an eye-opening evening as the Tribeca Screening Room presents the screening of Antagonist: How a Wonder Drug Got Sidelined, an investigative documentary by acclaimed journalist and filmmaker Ben Westhoff. This powerful film explores the untold story of how a life-saving medication, naltrexone, faced resistance from big-money interests despite its potential to combat opioid and alcohol addiction. Don’t miss this chance to engage in meaningful dialogue and learn how you can make a difference. Event Details: Wednesday, May 20, 2026, 6:30-9 pm6:30 pm — Panel Discussion featuring director Ben Westhoff, film subject Percy Menzies, Dr. Adam Bisaga, and Dr. Nikej Shaw7:00 pm – Film Admission is free! We invite you to consider donating to Assisted Recovery Centers of America Tribeca Screening Room375 Greenwich Street, New York, NY 10013 Visit AntagonistFilm.com for more information. Ben Westhoff is an award-winning investigative reporter and author of the best-selling book Fentanyl, Inc.: How Rogue Chemists Created the Deadliest Wave of the Opioid Epidemic. He has advised officials at the top levels of government about the opioid crisis, and has been interviewed as an expert commentator by CNN, NPR, and The New York Times. His new documentary, Antagonist, concerns the suppression of the opioid treatment drug naltrexone by big-money interests.    Percy Menzies is the president of Assisted Recovery Centers of America, LLC, a center for the treatment of alcoholism and drug addiction based in St. Louis, Missouri which was established in 2001.He worked for over 18 years for DuPont Pharmaceuticals; one of his roles was associate product director for naltrexone. He has worked closely with drug courts and provided training on the use of anti-craving medications for addiction to reduce recidivism within the criminal justice system. He has conducted workshops for a wide range of audiences both in the US and overseas on evidenced-based treatments for substance use disorders. He has been invited to serve on expert committees to develop guidelines for the treatment of addictive disorders and alcoholism. Percy is a member of the Missouri Opioid State Targeted Response Team. Percy serves on the Missouri State Advisory Council for the Division of Behavioral Health. Percy holds a master’s degree in pharmacy. Dr. Adam Bisaga is a Professor of Psychiatry at Columbia University College of Physicians and Surgeons and a Research Scientist at New York State Psychiatric Institute. His research has been continuously funded by NIH for 25 years and is focused on development and implementation of new medications and protocols to treat opioid and other substance use disorders, with recent focus on developing antagonist-based treatments. Dr. Bisaga authored more than 120 scientific publications and published a book “Overcoming Opioid Addiction“ written for both professional and lay audiences.  He is a member of UN Office of Drugs and Crime Expert Panel and a WHO consultant and actively collaborates with United Nations agencies to train healthcare providers and develop international treatment guidelines and programs. Additionally, Dr. Bisaga is at the forefront of integrating technology in addiction healthcare as the Medical Director of Ophelia, a telehealth company specializing in the treatment of opioid use disorder.  Dr. Nikej Shah is Founder/ CEO of Nirsum and Co-Inventor of its foundational intellectual property. He is also Co-Principal Investigator on Nirsum’s Cooperative Agreement with the National Institutes of Health (NIH)/ National Institute On Drug Abuse (NIDA). He brings over 25 years of experience in various roles as a physician-scientist, entrepreneur, and investor. Dr. Shah is also the Founder and Managing Partner of biotech-focused investment firm Mountain Brook Capital, the Founding Investor in Nirsum. He was previously a Senior Healthcare Portfolio Manager at Sigma Capital Management (now Point 72), and at HBK Capital Management. He was also a Managing Director at healthcare public/private equity investor Great Point Partners and Analyst at Ursus Capital. Dr. Shah earned an M.D. at the New York University School of Medicine and B.S. at Cornell University. He was a practicing emergency physician, having completed residency at the New York University/Bellevue Hospital Center, where he gained extensive experience with the acute treatment and referral of patients with opioid use disorder (OUD).

RecoVET

Premiere screening of Antagonist: How a Wonder Drug Got Sidelined, an investigative documentary by journalist Ben Westhoff

375 Greenwich St #2

General Admission

Free

Add a donation